TARDBP and amyotrophic lateral sclerosis: While studies of SOD1 levels in CSF have produced conflicting results, CSF levels of NfL—but not TDP-43—have consistently demonstrated utility in differentiating ALS from mimics such as Guillain–Barre syndrome [117,118].